Study of Safety, Efficacy and Tolerability of Secukinumab Versus Placebo, in Combination With SoC Therapy, in Patients With Active Lupus Nephritis
Clinical trial NCT04181762 · TERMINATED
Trial details
- NCT number
- NCT04181762
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-07
- Primary completion
- 2023-09-13
- Enrollment
- 275
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.